Clinical Immunology, Neuropharmacology and Drug Development

Autoimmunity and Neuropharmacology: New Insights

This track invites abstracts that explore the intersection of autoimmunity and neuropharmacology. Researchers should focus on the development of drugs that target autoimmune mechanisms in neurological diseases such as multiple sclerosis, lupus, and myasthenia gravis. The track will cover the latest insights into autoimmune pathogenesis and the challenges of developing safe and effective therapies. Attendees will learn about emerging treatments that aim to modulate the immune system and prevent autoimmune attacks on the nervous system, offering new hope for patients with autoimmune neurological disorders.